Virginia Tech Develops New Therapies to Treat the Most Aggressive Brain Cancers

Glioblastomas are unrelenting. About half of those diagnosed with this highly malignant form of brain cancer die within two years of diagnosis. Virginia Tech Carilion Research Institute Tackles Hard Problems Priorclave partner Virginia Tech is pursuing new therapies to treat people with gliobastomas at its Carilion Research Institute. Michael J. Friedlander, founding executive director of the … Continue reading “Virginia Tech Develops New Therapies to Treat the Most Aggressive Brain Cancers”